Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Pediatric Studies Characteristics - Detail
  • Print
  • Share
  • E-mail
-
 
Approval Date:  04/06/2011
 
Trade Name:  Invega
 
Generic or Proper Name (*):  paliperidone
 
Indications Studied:  Treatment of schizophrenia
 
Therapeutic Category:  Antipsychotic
 
Ages Studied:  10-17 years
 
Study #:  3
 
Study Type:  Safety
 
Study Design:  Open Label
 
No Patients:  282
 
No Centers:  60
 
No Countries:  11
 
BPCA(B), PREA(P):  B, P
 
-
-